Tirzepatide (Mounjaro) for Diabetes and Weight Loss
Tirzepatide is a dual GLP-1 and GIP analog that has got FDA approval for the treatment of patients with Type 2 Diabetes Mellitus. It has been associated with marked weight loss of approximately 22% which is even greater than Wegovy, an FDA-approved weight loss drug, however, Tirzepatide’s FDA approval as a weight loss drug is…
